1- Fagan TC, Sowers J. (1999). Type 2 diabetes mellitus- greater cardiovascular risks and greater benefits of therapy. Arch Intern Med; 159: 1033-34.
2- Haffiner SM, Lehto’S, Ronnemaa T, Pyorala K, Laakso M. (1998). Mortality from coronary heart disease in subjects with type2 diabetes and in non-diabetic subjects. N. Engl J. Med; 339: 229-34.
3- Fontbonne A. (1991). Relationship between diabetic dyslipoproteinemia and coronary heart disease risk in non-insulin dependent diabetes. Diabetes Metab Rev; 7: 179-89.
4- Hobanson JE, Austin MA. (1996). Plasma triglyceride level is a risk factor for cardiovascular disease independent of high density lipoprotein cholesterol level: a meta-analysis of population based prospective studies. J. Cardiovasc Risk; 3: 213-19.
6- Nicki R. Colledge Brian R. Walker stuart H. Ralston.(2010): Davidson's principles & practice of medicine 21st edition. 801-803.
7- Sapna, S. and Alok, M. L. (2008). A study on lipid profile levels of diabetics and Non- diabetics among Naini Region of Allahabad, India. Turk J. Biochem,33; (4); 138- 141.
9- Allain, G. C.; Poon, L. S. and Chan, C. S. G. (1974). Enzymatic determination of total serum cholesterol. Cline. Chem..; 20: 470.
10- Fossati, P. and Prencipe. L. (1982): Serum TG determination colorimetericlly with on enzyme that produces inflammatory reaction. Am j. pathol.;107: 397.
11- Kaplan, L. and Pesce, AJ. (1989): Clinical Chemistry Theory Analysis and correlation 2nd ed. Mosby Company United State of America.
12- Friedewald, W. T. Levy, R. J. and fredrickson, D. S. (1972): Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Cline chem. 18: 499- 502.
13- Wilson, P. W. (1998). Why treated dislipidemia. Soudi med. J.; 19 (4): 3776-381.
14- Flier, J. S., Kahn. C. R. and Roth, J. (1979): Receptors, antireceptor antibodies and mechanisms of insulin resistance; N. Engl. J. Med. 300, 8, 413-419.
15- Virtanen SM, Rasanen I., Virtanen M. et al.(1993): Association of serum lipids with metabolic control and diet in young subjects with insulin-dependent diabetes mellitus in finlans. Eur. J. cline. Nutr. 47 (2) 141-149.
16- Laakso M., (1997): Dyslipidemia morbidity and mortality in non insulin-dependent mellitus. J. diabetes complication; 11 (2): 137-141.
17- Betteridge DJ. (1994): Diabetic dyslipidemia. Am. J. med.; 96 (6) 25-31.
18- Mckenney JM. (1993): understanding and treating dyslipidemina associated with NIDDM and hypertension. Pharmacotherapy.; 13(4): 310-352 (abstract).
19- Manzato E, Crepaldi G.(1994): Dyslipoproteinemia in manifest diabetes. J.intern. med.; 736 (suppl): 27-31.
20- AL-Hamdani Raad Y. (2002): Pattern of dyslipidemia in diabetic patients. J. basic. Med. Sc. Al.-mustansyriah univ. Vol.2 No. 2: 107-110.
)
